ZVRA 주요 통계
고가
9.99
개시가
9.53
거래량
1.51M
저가
9.47
전일 종가
9.53
거래대금
14.76M
52주 최고가
15.04
상대 거래량
0.961
변동폭 (%)
5.46%
52주 최저가
7.16
회전율
2.57%
시가총액
563.07M
PER (TTM)
4.42
PER (연간)
6.807
PBR
2.74
PSR
4.61
주당순이익(EPS)
2.154
배당금(TTM)
0
배당수익률
0.00%
발행주식수
59.11M
통화 단위
USD
ZVRA 가격 수익률
7 일
30 일
90 일
180 일
연초 이후
1 년
ZVRA 자금 흐름 분포
ZVRA 일일 공매도 거래량
ZVRA 공매도 잔고 내역
ZVRA 주식 스냅샷
As of 2026-07-27, the Zevra Therapeutics, Inc. (ZVRA) stock price today is 9.71. Based on this price, the company has a market capitalization of $563.07M, with a P/E ratio of 4.42.
On 2026-07-27, ZVRA traded between 9.47 and 9.99. Today’s stock price is 2.53% above the daily low and 2.80% below the daily high, placing ZVRA 중간 부근에 its most recent trading range.
Trading volume currently stands at 1.51M, compared with an average daily volume of 1.58M. This suggests that trading activity is 평소 수준과 대체로 비슷한 than usual.
Over the past year, Zevra Therapeutics, Inc. shares have traded between 7.16 and 15.04. At today’s price, ZVRA is 35.61% above its 52-week low and 35.44% below its 52-week high.
ZVRA 관련 뉴스
소개 ZVRA
회사 이름
Zevra Therapeutics, Inc.
섹터
Health Technology
산업
Pharmaceuticals: Major
거래소
Nasdaq
직원 수
61
랏 크기
100
공식 웹사이트
통화 단위
USD
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.
Related Stocks
